ANTIMERS AND ANTIMERIC CONJUGATION

There is disclosed an antibody and antibody-drug conjugate for targeting drug delivery as well as a class of chemicals, termed an "antimer." The antimer is designed to "fit" the drug by combining multiple non-covalent interactions between functional groups on the drug and opposin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PRIEST, JOHN H, MORGAN, ALTON C., JR, FRITZBERG, ALAN R, ANDERSON, DAVID C, ABRAMS, PAUL G, RENO, JOHN M, SIVAM, GOWSALA P, SRINIVASAN, ANANTHACHARI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PRIEST, JOHN H
MORGAN, ALTON C., JR
FRITZBERG, ALAN R
ANDERSON, DAVID C
ABRAMS, PAUL G
RENO, JOHN M
SIVAM, GOWSALA P
SRINIVASAN, ANANTHACHARI
description There is disclosed an antibody and antibody-drug conjugate for targeting drug delivery as well as a class of chemicals, termed an "antimer." The antimer is designed to "fit" the drug by combining multiple non-covalent interactions between functional groups on the drug and opposing functional groups on the antimer. The net result on the antibody-antimer-drug conjugate is a drug stably bound to the antimer so as not to dissociate during in vivo administration, but not so tightly bound to allow drug dissociation from the conjugate without significant loss of activity and retaining the drug's ability to bind to a higher affinity site on the or within the target cell.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0329184A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0329184A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0329184A33</originalsourceid><addsrcrecordid>eNrjZFBy9Avx9HUNClZw9HNRgHI8nRWc_f28Qt0dQzz9_XgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgIGxkaWhhYmjsTERSgD68SIe</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIMERS AND ANTIMERIC CONJUGATION</title><source>esp@cenet</source><creator>PRIEST, JOHN H ; MORGAN, ALTON C., JR ; FRITZBERG, ALAN R ; ANDERSON, DAVID C ; ABRAMS, PAUL G ; RENO, JOHN M ; SIVAM, GOWSALA P ; SRINIVASAN, ANANTHACHARI</creator><creatorcontrib>PRIEST, JOHN H ; MORGAN, ALTON C., JR ; FRITZBERG, ALAN R ; ANDERSON, DAVID C ; ABRAMS, PAUL G ; RENO, JOHN M ; SIVAM, GOWSALA P ; SRINIVASAN, ANANTHACHARI</creatorcontrib><description>There is disclosed an antibody and antibody-drug conjugate for targeting drug delivery as well as a class of chemicals, termed an "antimer." The antimer is designed to "fit" the drug by combining multiple non-covalent interactions between functional groups on the drug and opposing functional groups on the antimer. The net result on the antibody-antimer-drug conjugate is a drug stably bound to the antimer so as not to dissociate during in vivo administration, but not so tightly bound to allow drug dissociation from the conjugate without significant loss of activity and retaining the drug's ability to bind to a higher affinity site on the or within the target cell.</description><edition>4</edition><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1990</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19900523&amp;DB=EPODOC&amp;CC=EP&amp;NR=0329184A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19900523&amp;DB=EPODOC&amp;CC=EP&amp;NR=0329184A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PRIEST, JOHN H</creatorcontrib><creatorcontrib>MORGAN, ALTON C., JR</creatorcontrib><creatorcontrib>FRITZBERG, ALAN R</creatorcontrib><creatorcontrib>ANDERSON, DAVID C</creatorcontrib><creatorcontrib>ABRAMS, PAUL G</creatorcontrib><creatorcontrib>RENO, JOHN M</creatorcontrib><creatorcontrib>SIVAM, GOWSALA P</creatorcontrib><creatorcontrib>SRINIVASAN, ANANTHACHARI</creatorcontrib><title>ANTIMERS AND ANTIMERIC CONJUGATION</title><description>There is disclosed an antibody and antibody-drug conjugate for targeting drug delivery as well as a class of chemicals, termed an "antimer." The antimer is designed to "fit" the drug by combining multiple non-covalent interactions between functional groups on the drug and opposing functional groups on the antimer. The net result on the antibody-antimer-drug conjugate is a drug stably bound to the antimer so as not to dissociate during in vivo administration, but not so tightly bound to allow drug dissociation from the conjugate without significant loss of activity and retaining the drug's ability to bind to a higher affinity site on the or within the target cell.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1990</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBy9Avx9HUNClZw9HNRgHI8nRWc_f28Qt0dQzz9_XgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgIGxkaWhhYmjsTERSgD68SIe</recordid><startdate>19900523</startdate><enddate>19900523</enddate><creator>PRIEST, JOHN H</creator><creator>MORGAN, ALTON C., JR</creator><creator>FRITZBERG, ALAN R</creator><creator>ANDERSON, DAVID C</creator><creator>ABRAMS, PAUL G</creator><creator>RENO, JOHN M</creator><creator>SIVAM, GOWSALA P</creator><creator>SRINIVASAN, ANANTHACHARI</creator><scope>EVB</scope></search><sort><creationdate>19900523</creationdate><title>ANTIMERS AND ANTIMERIC CONJUGATION</title><author>PRIEST, JOHN H ; MORGAN, ALTON C., JR ; FRITZBERG, ALAN R ; ANDERSON, DAVID C ; ABRAMS, PAUL G ; RENO, JOHN M ; SIVAM, GOWSALA P ; SRINIVASAN, ANANTHACHARI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0329184A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1990</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PRIEST, JOHN H</creatorcontrib><creatorcontrib>MORGAN, ALTON C., JR</creatorcontrib><creatorcontrib>FRITZBERG, ALAN R</creatorcontrib><creatorcontrib>ANDERSON, DAVID C</creatorcontrib><creatorcontrib>ABRAMS, PAUL G</creatorcontrib><creatorcontrib>RENO, JOHN M</creatorcontrib><creatorcontrib>SIVAM, GOWSALA P</creatorcontrib><creatorcontrib>SRINIVASAN, ANANTHACHARI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PRIEST, JOHN H</au><au>MORGAN, ALTON C., JR</au><au>FRITZBERG, ALAN R</au><au>ANDERSON, DAVID C</au><au>ABRAMS, PAUL G</au><au>RENO, JOHN M</au><au>SIVAM, GOWSALA P</au><au>SRINIVASAN, ANANTHACHARI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIMERS AND ANTIMERIC CONJUGATION</title><date>1990-05-23</date><risdate>1990</risdate><abstract>There is disclosed an antibody and antibody-drug conjugate for targeting drug delivery as well as a class of chemicals, termed an "antimer." The antimer is designed to "fit" the drug by combining multiple non-covalent interactions between functional groups on the drug and opposing functional groups on the antimer. The net result on the antibody-antimer-drug conjugate is a drug stably bound to the antimer so as not to dissociate during in vivo administration, but not so tightly bound to allow drug dissociation from the conjugate without significant loss of activity and retaining the drug's ability to bind to a higher affinity site on the or within the target cell.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_EP0329184A3
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ANTIMERS AND ANTIMERIC CONJUGATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A36%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PRIEST,%20JOHN%20H&rft.date=1990-05-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0329184A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true